Marc S. Collett

10.4k total citations · 3 hit papers
112 papers, 8.3k citations indexed

About

Marc S. Collett is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Marc S. Collett has authored 112 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 41 papers in Infectious Diseases and 41 papers in Genetics. Recurrent topics in Marc S. Collett's work include Virus-based gene therapy research (37 papers), Animal Virus Infections Studies (26 papers) and Viral Infections and Immunology Research (23 papers). Marc S. Collett is often cited by papers focused on Virus-based gene therapy research (37 papers), Animal Virus Infections Studies (26 papers) and Viral Infections and Immunology Research (23 papers). Marc S. Collett collaborates with scholars based in United States, Netherlands and United Kingdom. Marc S. Collett's co-authors include Raymond L. Erikson, A F Purchio, E Erikson, Paul Warrener, Joan S. Brugge, R L Erikson, Susan Belzer, Anthony J. Faras, Ernest F. Retzel and James Tamura and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Marc S. Collett

112 papers receiving 7.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protein kinase activity associated with the avian sarcoma virus src gene product.

1978 963 citations Marc S. Collett, Raymond L. Erikson profile →
Avian sarcoma virus-transforming protein, pp60src shows protein kinase activity specific for tyrosine

1980 450 citations Marc S. Collett, A F Purchio et al. profile →
Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes

1993 264 citations JoAnn Suzich, Paul Warrener et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc S. Collett United States	51	3.3k	2.5k	2.0k	1.8k	1.7k	112	8.3k
Stephen Oroszlan United States	59	4.5k 1.4×	3.4k 1.4×	2.3k 1.2×	1.2k 0.7×	470 0.3×	197	11.2k
Roland R. Rueckert United States	49	3.4k 1.0×	2.0k 0.8×	879 0.4×	857 0.5×	3.2k 1.9×	101	8.1k
Akio Nomoto Japan	56	4.8k 1.5×	3.2k 1.3×	1.3k 0.7×	530 0.3×	4.8k 2.9×	176	10.6k
Stephen Goodbourn United Kingdom	47	3.5k 1.1×	2.8k 1.1×	1.5k 0.8×	1.1k 0.6×	788 0.5×	93	10.7k
Raymond V. Gilden United States	42	2.2k 0.7×	1.1k 0.4×	2.7k 1.4×	1.1k 0.6×	407 0.2×	194	7.0k
Vadim I. Agol Russia	50	3.6k 1.1×	2.7k 1.1×	605 0.3×	702 0.4×	4.7k 2.8×	162	7.0k
Wade P. Parks United States	46	3.4k 1.0×	2.6k 1.1×	2.5k 1.3×	540 0.3×	347 0.2×	129	9.4k
Richard E. Randall United Kingdom	53	2.6k 0.8×	3.7k 1.5×	1.3k 0.7×	793 0.4×	672 0.4×	145	11.3k
María Salas Spain	48	2.0k 0.6×	1.2k 0.5×	512 0.3×	3.0k 1.7×	1.5k 0.9×	208	7.2k
Dani P. Bolognesi United States	53	4.0k 1.2×	5.3k 2.1×	2.0k 1.0×	838 0.5×	319 0.2×	175	13.5k

Countries citing papers authored by Marc S. Collett

Since Specialization

Citations

This map shows the geographic impact of Marc S. Collett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc S. Collett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc S. Collett more than expected).

Fields of papers citing papers by Marc S. Collett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc S. Collett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc S. Collett. The network helps show where Marc S. Collett may publish in the future.

Co-authorship network of co-authors of Marc S. Collett

This figure shows the co-authorship network connecting the top 25 collaborators of Marc S. Collett. A scholar is included among the top collaborators of Marc S. Collett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc S. Collett. Marc S. Collett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McKinlay, M A, Marc S. Collett, Mark A. Pallansch, et al.. (2014). Progress in the Development of Poliovirus Antiviral Agents and Their Essential Role in Reducing Risks That Threaten Eradication. The Journal of Infectious Diseases. 210(suppl 1). S447–S453. 43 indexed citations

Liu, Hongmei, Jason Roberts, Deborah Moore, et al.. (2012). Characterization of Poliovirus Variants Selected for Resistance to the Antiviral Compound V-073. Antimicrobial Agents and Chemotherapy. 56(11). 5568–5574. 21 indexed citations

Rumyantsev, Alexander A., Zhenxi Zhang, Qingsheng Gao, et al.. (2009). Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus. Virology. 396(2). 329–338. 14 indexed citations

Kneteman, Norman M., Anita Y. M. Howe, Tiejun Gao, et al.. (2008). HCV796. Hepatology. 49(3). 745–752. 98 indexed citations

Collett, Marc S. & Neal S. Young. (1994). Prospects for a human B19 parvovirus vaccine. Reviews in Medical Virology. 4(2). 91–103. 3 indexed citations

Górny, Miroslaw K., et al.. (1993). Generation of Neutralizing Anti-B19 Parvovirus Human Monoclonal Antibodies from Patients Infected with Human Immunodeficiency Virus. The Journal of Infectious Diseases. 168(3). 580–585. 13 indexed citations

Bansal, Geetha P., Jeanine Hatfield, Frances Dunn, et al.. (1993). Candidate Recombinant Vaccine for Human B19 Parvovirus. The Journal of Infectious Diseases. 167(5). 1034–1044. 95 indexed citations

Collett, Marc S.. (1992). Molecular genetics of pestiviruses. Comparative Immunology Microbiology and Infectious Diseases. 15(3). 145–154. 83 indexed citations

Rosenfeld, Stephen J., Kohji Yoshimoto, Sachiko Kajigaya, et al.. (1992). Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.. Journal of Clinical Investigation. 89(6). 2023–2029. 87 indexed citations

10.

Collett, Marc S., et al.. (1991). Bovine viral diarrhea virus genomic organization. PubMed. 3. 19–27. 80 indexed citations

11.

Suzich, JoAnn, et al.. (1989). Rift valley fever virus M segment: Phlebovirus expression strategy and protein glycosylation. Virology. 170(2). 505–510. 53 indexed citations

12.

Schmaljohn, Connie S., Michael D. Parker, Willis H. Ennis, et al.. (1989). Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. Virology. 170(1). 184–192. 75 indexed citations

13.

Wasmoen, Terri, et al.. (1988). Rift valley fever virus M segment: Cellular localization of M segment-encoded proteins. Virology. 166(1). 275–280. 47 indexed citations

14.

Collett, Marc S., Dennis K. Anderson, & Ernest F. Retzel. (1988). Comparisons of the Pestivirus Bovine Viral Diarrhoea Virus with Members of the Flaviviridae. Journal of General Virology. 69(10). 2637–2643. 139 indexed citations

15.

Collett, Marc S., Kathleen S. Keegan, Padma Sridhar, et al.. (1985). Protective subunit immunogens to rift valley fever virus from bacteria and recombinant vaccinia virus. Virus Research. 3. 62–62. 24 indexed citations

16.

Collett, Marc S., Susan Belzer, & A F Purchio. (1984). Structurally and functionally modified forms of pp60v-src in Rous sarcoma virus-transformed cell lysates.. Molecular and Cellular Biology. 4(7). 1213–1220. 21 indexed citations

17.

Collett, Marc S., et al.. (1984). Enzymatic characteristics of pp60^v‐src isolated from vanadium‐treated transformed cells. Journal of Cellular Biochemistry. 26(2). 95–106. 6 indexed citations

18.

Purchio, A F, Susan K. Wells, & Marc S. Collett. (1983). Increase in the Phosphotransferase Specific Activity of Purified Rous Sarcoma Virus pp60 ^{v- src} Protein After Incubation with ATP Plus Mg ²⁺. Molecular and Cellular Biology. 3(9). 1589–1597. 15 indexed citations

19.

Erikson, Raymond L., Marc S. Collett, E Erikson, & A F Purchio. (1980). Towards a molecular description of cell transformation by avian sarcoma virus. Proceedings of the Royal Society of London. Series B, Biological sciences. 210(1180). 387–396. 4 indexed citations

20.

Collett, Marc S. & Anthony J. Faras. (1975). Elimination of residual RNase activity from purified preparations of RNA-directed DNA polymerase. Biochemical and Biophysical Research Communications. 67(3). 946–955. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact